Why Canopy Growth (TSX:WEED) Just Got a Whole Lot Closer to Posting a Profit

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) recently received a licence for an outdoor site that could help the company bring down its costs and improve its bottom line.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Canopy Growth (TSX:WEED)(NYSE:CGC) knows that it needs to find a way to cut down its costs. With a big loss in its most recent quarterly earnings, investors have started to distance themselves from the stock with the share price falling again. And with Canopy Growth recently saying that it planned to be EBITDA positive, the pressure is on for the company to produce much stronger results.

One way it can do that is by bringing its costs down. Earlier this week, the company announced that it had received a new licence from Health Canada to produce cannabis at an outdoor site in Saskatchewan. With an outdoor operation, Canopy Growth can produce cannabis at a much lower cost than at its indoor facilities. The problem is that there’s less control when it comes to growing cannabis outside, and that can create more variability in the end product.

However, it’s an important step for the company to take, as it needs to find ways to improve its margins, and growing outside could be a way to help bring its cost of sales down. At 160 acres, the site is a significant one, and it will help Canopy Growth benefit from economies of scale. Producing at such a large volume will definitely improve its overall cost structure.

Will higher margins be enough to land the company in the black?

The problem is that even with a higher margin, the rate at which operating expenses have been rising may still negate any improvement in gross profit. Since the industry is experiencing high growth, costs are inevitably going to rise, as companies open more locations and expand their facilities.

It isn’t that the costs aren’t warranted; it’s that they’re getting out of control. With significant sales growth, we would normally expect to see some improvement in the bottom line, as margins from the incremental sales flow through to the bottom line, but that just hasn’t been happening.

The good news, however, is that with the launch of edibles, Canopy Growth will be able to diversify its product offerings a bit and could improve its margins by doing so. And once things calm down in the Canadian market, we shouldn’t continue to see the big increases in operating expenses either.

Now that things are finally starting to normalize in the industry, the pressure will be on Canopy Growth to prove that it can run a tighter ship. The company can shift its focus from acquisitions and work on cleaning up its house to try and cut out any redundancies and inefficiencies that have resulted from its aggressive growth strategy.

It’s going to be a big test for Canopy Growth to be able to show that it can make significant progress in trimming its expenses and getting closer to breakeven. Now with cannabis investors having so many different pot stocks to choose from, the company is going to have to provide investors with more than just promises of future growth.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

See the Top Stocks * Returns as of 2/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

If You Thought Apple and Microsoft Were Big, You Need to Read This.

The steel industry produced the world's first $1 billion company in 1901, and it wasn't until 117 years later that technology giant Apple became the first-ever company to reach a $1 trillion valuation.

But what if I told you artificial intelligence (AI) is about to accelerate the pace of value creation? AI has the potential to produce several trillion-dollar companies in the future, and The Motley Fool is watching one very closely right now.

Don't fumble this potential wealth-building opportunity by navigating it alone. The Motley Fool has a proven track record of picking revolutionary growth stocks early, from Netflix to Amazon, so become a premium member today.

See the 'AI Supercycle' Stock

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »